Search

Author/Creator Oaknin, Ana

62. Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial. Issue 5 (May 2021)

Authors:
Friedlander, Michael; Moore, Kathleen N; Colombo, Nicoletta; Scambia, Giovanni; Kim, Byoung-Gie; Oaknin, Ana; Lisyanskaya, Alla; Sonke, Gabe S; Gourley, Charlie; Banerjee, Susana; Oza, Amit; González-Martín, Antonio; Aghajanian, Carol; Bradley, William H; Liu, Joyce; Mathews, Cara; Selle, Frédéri...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
632
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

63. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Issue 5 (28th February 2020)

Authors:
Chase, Dana; Huang, Helen Q; Monk, Bradley J; Ramondetta, Lois Michelle; Penson, Richard T; Gil, Karen; Landrum, Lisa M; Leitao, Mario; Oaknin, Ana; Huh, Warner K; Pulaski, Heather L; Robison, Katina; Guntupalli, Saketh R; Richardson, Debra; Salani, Ritu; Sill, Michael W; Wenzel, Lari B; Tewari, ...
Journal:
International journal of gynecological cancer
Issue:
Volume 30:Issue 5(2020)
Page Start:
596
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

65. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2020)

Authors:
Ledermann, Jonathan A; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew R; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Ar...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 5(2020)
Page Start:
710
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

66. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Issue 1 (January 2017)

Authors:
Swisher, Elizabeth M; Lin, Kevin K; Oza, Amit M; Scott, Clare L; Giordano, Heidi; Sun, James; Konecny, Gottfried E; Coleman, Robert L; Tinker, Anna V; O'Malley, David M; Kristeleit, Rebecca S; Ma, Ling; Bell-McGuinn, Katherine M; Brenton, James D; Cragun, Janiel M; Oaknin, Ana; Ray-Coquard, Isabe...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

67. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Issue 1 (January 2017)

Authors:
Swisher, Elizabeth M; Lin, Kevin K; Oza, Amit M; Scott, Clare L; Giordano, Heidi; Sun, James; Konecny, Gottfried E; Coleman, Robert L; Tinker, Anna V; O'Malley, David M; Kristeleit, Rebecca S; Ma, Ling; Bell-McGuinn, Katherine M; Brenton, James D; Cragun, Janiel M; Oaknin, Ana; Ray-Coquard, Isabe...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

68. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10106 (28th October 2017)

Authors:
Coleman, Robert L; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstron...
Journal:
Lancet
Issue:
Volume 390:Issue 10106(2017)
Page Start:
1949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

69. Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3. Issue 7 (8th June 2021)

Authors:
Clamp, Andrew R; Lorusso, Domenica; Oza, Amit M; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Amenedo Gancedo, Margarita; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Ban...
Journal:
International journal of gynecological cancer
Issue:
Volume 31:Issue 7(2021)
Page Start:
949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

70. Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression‐free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3. Issue 7 (July 2021)

Authors:
Clamp, Andrew R; Lorusso, Domenica; Oza, Amit M; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Ban...
Journal:
International journal of gynecological cancer
Issue:
Volume 31:Issue 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗